Summary of findings for all doses of nasal decongestant vs placebo
Primary outcome: subjective symptom score (mean) ‐ 3 hours after dosing · adult patients with the common cold
3 findings from 1 review
- no estimate extracted3 studies · 146 participantsModerate
- no estimate extracted2 studies · 85 participantsLow
- no estimate extracted1 study · 61 participantsGRADE not reported